Stephen Mayo
Insider Reports History
- Location
- Kenilworth, NJ
- Signature
- /s/ Cristin L. Rothfuss, as Attorney-in-Fact for Stephen Mayo
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Stephen Mayo:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Merck & Co., Inc. | Director | Phantom Stock | 12,540 | $963,560 | $76.84 | 30 May 2025 | Direct |
| Sarepta Therapeutics, Inc. | Director | Common Stock | 1,765 | $30,040 | $17.02 | 12 Mar 2026 | Direct |
| Merck & Co., Inc. | Director | Common Stock | 100 | $7,663 | $76.63 | 30 May 2025 | Direct |
| Allogene Therapeutics, Inc. | Director | Restricted Stock Unit | 95,400 | 18 Jun 2025 | Direct |
Insider Reports Filed by Stephen Mayo
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics, Inc. | 12 Mar 2026 | 1 | -$123,208 | 4 | Director | 13 Mar 2026, 20:03 |
| ALLO | Allogene Therapeutics, Inc. | 18 Jun 2025 | 1 | $0 | 4 | Director | 23 Jun 2025, 21:03 |
| MRK | Merck & Co., Inc. | 30 May 2025 | 1 | +$220,000 | 4 | Director | 03 Jun 2025, 13:14 |
| SRPT | Sarepta Therapeutics, Inc. | 10 Mar 2025 | 2 | $0 | 4 | Director | 11 Mar 2025, 20:00 |
| ALLO | Allogene Therapeutics, Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 17:35 |
| MRK | Merck & Co., Inc. | 31 May 2024 | 1 | +$220,000 | 4 | Director | 04 Jun 2024, 14:32 |
| SRPT | Sarepta Therapeutics, Inc. | 05 Mar 2024 | 1 | -$385,480 | 4 | Director | 06 Mar 2024, 20:00 |
| SRPT | Sarepta Therapeutics, Inc. | 01 Mar 2024 | 2 | $0 | 4 | Director | 05 Mar 2024, 20:00 |
| ALLO | Allogene Therapeutics, Inc. | 07 Aug 2023 | 1 | -$42,855 | 4 | Director | 09 Aug 2023, 16:07 |
| ALLO | Allogene Therapeutics, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 16:57 |
| MRK | Merck & Co., Inc. | 26 May 2023 | 1 | +$220,000 | 4 | Director | 31 May 2023, 14:39 |
| SRPT | Sarepta Therapeutics, Inc. | 06 Mar 2023 | 2 | $0 | 4 | Director | 08 Mar 2023, 19:00 |
| SRPT | Sarepta Therapeutics, Inc. | 17 Nov 2022 | 1 | -$94,311 | 4 | Director | 21 Nov 2022, 19:00 |
| ALLO | Allogene Therapeutics, Inc. | 08 Jul 2022 | 2 | $0 | 4 | Director | 12 Jul 2022, 16:48 |
| ALLO | Allogene Therapeutics, Inc. | 08 Jul 2022 | 0 | $0 | 3 | Director | 12 Jul 2022, 16:37 |
| MRK | Merck & Co., Inc. | 27 May 2022 | 1 | +$220,000 | 4 | Director | 01 Jun 2022, 16:19 |
| SRPT | Sarepta Therapeutics, Inc. | 07 Mar 2022 | 2 | $0 | 4 | Director | 09 Mar 2022, 19:02 |
| SRPT | Sarepta Therapeutics, Inc. | 16 Nov 2021 | 2 | $0 | 4 | Director | 17 Nov 2021, 19:06 |
| SRPT | Sarepta Therapeutics, Inc. | 16 Nov 2021 | 0 | $0 | 3 | Director | 17 Nov 2021, 19:03 |
| MRK | Merck & Co., Inc. | 28 May 2021 | 1 | +$200,000 | 4 | Director | 02 Jun 2021, 13:52 |